He, Chao <br/><br/>
Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.  [electronic resource] 

 -  Medicine  Apr 2017 
 - e6606 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000006606  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Comorbidity<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Sex Factors<br/>Thymalfasin<br/>Thymosin--administration & dosage<br/>Young Adult